Institutional investors control 2.62% of the outstanding shares in RNN. This represents a greater percentage of ownership than at almost any other company in the Biotechnology industry. Additionally, during the quarter ended September 2013, these large investors purchased a net $882.6 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SPHERA FUND MANAGEMENT LTD. Bought 1.5 Million shares of Rexahn Pharmaceuticals In...
MORGAN STANLEY & CO. LLC Bought 27.1 Thousand shares of Rexahn Pharmaceuticals In...